Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Molecules ; 26(13)2021 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-34203134

RESUMEN

Heartburn and non-cardiac chest pain are the predominant symptoms in many esophageal disorders, such as gastroesophageal reflux disease (GERD), non-erosive reflux disease (NERD), functional heartburn and chest pain, and eosinophilic esophagitis (EoE). At present, neuronal mechanisms underlying the process of interoceptive signals in the esophagus are still less clear. Noxious stimuli can activate a subpopulation of primary afferent neurons at their nerve terminals in the esophagus. The evoked action potentials are transmitted through both the spinal and vagal pathways to their central terminals, which synapse with the neurons in the central nervous system to induce esophageal nociception. Over the last few decades, progress has been made in our understanding on the peripheral and central neuronal mechanisms of esophageal nociception. In this review, we focus on the roles of capsaicin-sensitive vagal primary afferent nodose and jugular C-fiber neurons in processing nociceptive signals in the esophagus. We briefly compare their distinctive phenotypic features and functional responses to mechanical and chemical stimulations in the esophagus. Then, we summarize activation and/or sensitization effects of acid, inflammatory cells (eosinophils and mast cells), and mediators (ATP, 5-HT, bradykinin, adenosine, S1P) on these two nociceptive C-fiber subtypes. Lastly, we discuss the potential roles of capsaicin-sensitive esophageal afferent nerves in processing esophageal sensation and nociception. A better knowledge of the mechanism of nociceptive signal processes in primary afferent nerves in the esophagus will help to develop novel treatment approaches to relieve esophageal nociceptive symptoms, especially those that are refractory to proton pump inhibitors.


Asunto(s)
Potenciales de Acción/efectos de los fármacos , Capsaicina/uso terapéutico , Esófago/metabolismo , Pirosis/dietoterapia , Nocicepción/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Nervio Vago/metabolismo , Animales , Esófago/inervación , Esófago/patología , Pirosis/metabolismo , Pirosis/patología , Humanos , Nervio Vago/patología
2.
Complement Ther Med ; 41: 225-230, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30477844

RESUMEN

OBJECTIVES: Several common supplements are used by a significant number of patients affected by gastrointestinal (GI) disorders to improve symptoms and quality of life. We investigated the impact of GI symptom improvement with the use of fiber, STW 5, probiotics, and peppermint oil in relation to overall GI pain and quality of life via an online survey. DESIGN: We used a cross-sectional, descriptive, correlation design. A Qualtrics online survey was utilized to collect data from January to June 2013 through various websites. Areas evaluated included participant demographics, use of supplements, and gastrointestinal symptom severity. RESULTS: The rate of supplement use among patients with GI disorders was high (90% in past year) and consultation with healthcare providers was reported by 80%. Participants who completed the survey (n = 68) reported a strong correlation between GI symptom severity and overall quality of life (r2 = 0.8682, p < 0.001). The use of fiber improved GI symptom severity while both STW 5 and probiotics were linked to specific improvements. CONCLUSIONS: Persons with chronic GI disorders often choose the complementary use of common supplements to mitigate GI symptoms and consult with their healthcare providers frequently. The use of STW 5 and probiotics specifically is linked to overall reduction in GI symptoms and improvement of quality of life.


Asunto(s)
Dolor Abdominal , Estreñimiento , Fibras de la Dieta/uso terapéutico , Suplementos Dietéticos/estadística & datos numéricos , Aceites de Plantas/uso terapéutico , Probióticos/uso terapéutico , Dolor Abdominal/dietoterapia , Dolor Abdominal/epidemiología , Adulto , Estreñimiento/dietoterapia , Estreñimiento/epidemiología , Estudios Transversales , Diarrea/dietoterapia , Diarrea/epidemiología , Femenino , Pirosis/dietoterapia , Pirosis/epidemiología , Humanos , Masculino , Mentha piperita , Persona de Mediana Edad , Encuestas y Cuestionarios
3.
BMC Gastroenterol ; 14: 144, 2014 Aug 14.
Artículo en Inglés | MEDLINE | ID: mdl-25125219

RESUMEN

BACKGROUND: Gastroesophageal reflux disease (GERD) is the most common gastrointestinal disease, and the cost of health care and lost productivity due to GERD is extremely high. Recently described side effects of long-term acid suppression have increased the interest in nonpharmacologic methods for alleviating GERD symptoms. We aimed to examine whether GERD patients follow recommended dietary guidelines, and if adherence is associated with the severity and frequency of reflux symptoms. METHODS: We conducted a population-based cross-sectional study within the Kaiser Permanente Northern California population, comparing 317 GERD patients to 182 asymptomatic population controls. All analyses adjusted for smoking and education. RESULTS: GERD patients, even those with moderate to severe symptoms or frequent symptoms, were as likely to consume tomato products and large portion meals as GERD-free controls and were even more likely to consume soft drinks and tea [odds ratio (OR) = 2.01 95% confidence interval (CI) 1.12-3.61; OR = 2.63 95% CI 1.24-5.59, respectively] and eat fried foods and high fat diet. The only reflux-triggering foods GERD patients were less likely to consume were citrus and alcohol [OR = 0.59; 95% CI: 0.35-0.97 for citrus; OR = 0.41 95% CI 0.19-0.87 for 1 + drink/day of alcohol]. The associations were similar when we excluded users of proton pump inhibitors. CONCLUSIONS: GERD patients consume many putative GERD causing foods as frequently or even more frequently than asymptomatic patients despite reporting symptoms. These findings suggest that, if dietary modification is effective in reducing GERD, substantial opportunities for nonpharmacologic interventions exist for many GERD patients.


Asunto(s)
Conducta Alimentaria , Reflujo Gastroesofágico/dietoterapia , Pirosis/dietoterapia , Cooperación del Paciente/estadística & datos numéricos , Adulto , Anciano , Consumo de Bebidas Alcohólicas/epidemiología , Bebidas Gaseosas , Estudios de Casos y Controles , Citrus , Estudios Transversales , Dieta con Restricción de Grasas/estadística & datos numéricos , Dieta Alta en Grasa/estadística & datos numéricos , Femenino , Reflujo Gastroesofágico/complicaciones , Pirosis/etiología , Humanos , Solanum lycopersicum , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Fumar/epidemiología , , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA